Kalimuthusamy Natarajaseenivasan

Dr. Kalimuthusamy Natarajaseenivasan

1. Medical Microbiology Laboratory, Department of Microbiology, Centre for Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli 620 024, Tamil Nadu, India
+1

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
KSKrishnamoorthi Sumaiya
Krishnamoorthi Sumaiya
DLDianne Langford
Dianne Langford
KNKalimuthusamy Natarajaseenivasan
Kalimuthusamy Natarajaseenivasan
SSSanthanam Shanmughapriya
Santhanam Shanmughapriya

23 July 2020 in Ageing Research Reviews
Verified
Journal Article
Closed access
SSSanthanam Shanmughapriya
Santhanam Shanmughapriya
DLDianne Langford
Dianne Langford
KNKalimuthusamy Natarajaseenivasan
Kalimuthusamy Natarajaseenivasan

1 October 2019 in Progress in Neurobiology
Verified
Journal Article
Closed access
BCBianca Cotto
Bianca Cotto
KNKalimuthusamy Natarajaseenivasan
Kalimuthusamy Natarajaseenivasan
Dianne LangfordDianne Langford
Dianne Langford

21 May 2013 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
VRVeerapandian Raja
Veerapandian Raja
KNKalimuthusamy Natarajaseenivasan
Kalimuthusamy Natarajaseenivasan
Pathogenic Leptospira species are important human and animal pathogen that causes leptospirosis, with more than half a million cases reported annually but little is known regarding the true incidence of leptospirosis due to the limitations in diagnosis. Proteins embedded in the outer membrane are found to be prime drug targets due to its key role as receptors for cellular communication and gatekeepers for iron and substrate transport across cell membranes. The major key issues to be addressed to overcome the disease burden of leptospirosis are: need to identify the genes that turn on in vivo; development of rapid diagnostic methods to facilitate the early diagnosis and to develop a universal vaccine. Recent whole genome sequencing of Leptospira species and development of in silico analysis tools have led to the identification of a large number of leptospiral virulence genes, metabolic pathways and surface protein secretion systems that represent potential new targets for the development of anti-leptospiral drug, vaccine and diagnostic strategies. This review surveys the different types of outer membrane proteins (OMPs) of Leptospira and combines all the novel features of OMPs reported till date and put forth some views for future research.

1 April 2013 in Pathogens and Global Health
Verified
Journal Article
Closed access
KVKumaresan Vedhagiri
Kumaresan Vedhagiri
SVSridhar Velineni
Sridhar Velineni
JTJohn F Timoney
John F Timoney
SSSanthanam Shanmughapriya
Santhanam Shanmughapriya
PVPaluru Vijayachari
Paluru Vijayachari
KNKalimuthusamy Natarajaseenivasan
Kalimuthusamy Natarajaseenivasan
Successful treatment of leptospirosis is heavily dependent on early diagnosis and prompt initiation of antibiotic therapy. An ELISA test to detect specific IgM antibodies against LipL32 for early diagnosis of leptospirosis is described and evaluated here. One thousand one hundred and eighty sera from clinically suspected leptospirosis cases were enrolled together with 109 healthy volunteers selected from an endemic area between October 2007 and January 2010. Patients were categorized based on their clinical signs and symptoms. Sera were screened for leptospiral antibodies by the microscopic agglutination test (MAT) using a panel of locally circulating serovars followed by enzyme-linked immunosorbent assay (ELISA) based on recombinant LipL32 from Leptospira interrogans serovar Autumnalis strain N2. The sensitivity and specificity of the ELISA test were determined to establish its diagnostic efficiency. The cut-off value was determined to be 0·205. Overall sensitivity and specificity compared to the MAT were found to be 96·4 and 90·4%, respectively. The LipL32-specific IgM ELISA had good sensitivity and acceptable specificity and may be a candidate for the early serodiagnosis of human leptospirosis.

18 November 2004 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
KNKalimuthusamy Natarajaseenivasan
Kalimuthusamy Natarajaseenivasan
PVP. Vijayachari
P. Vijayachari
SSSAMEER SHARMA
SAMEER SHARMA
SRSubarna Roy
Subarna Roy
ASA.P. Sugunan
A.P. Sugunan
SSS.C. Sehgal
S.C. Sehgal